Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis

被引：0
|
作者：
Didem S. Dede
Cagatay Arslan
Kadri Altundag
机构：
[1] Hacettepe University Institute of Oncology,Department of Medical Oncology
来源：
Medical Oncology | 2010年 / 27卷
关键词：
Breast Cancer; Epidermal Growth Factor Receptor; Breast Cancer Patient; Progesterone Receptor; Recurrent Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1429 / 1429
相关论文
共 50 条
  • [21] Clinical value of TPS, CEA and CA 15-3 in breast cancer patients
    Blijlevens, NMA
    Oosterhuis, WP
    Oosten, HR
    Mulder, NH
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2711 - 2716
  • [22] Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer
    Fehm, T
    Jäger, W
    Kramer, S
    Sohn, C
    Solomayer, E
    Wallwiener, D
    Gebauer, G
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1987 - 1992
  • [23] CEA, CA 15-3 and MCA: Comparative clinical relevance in breast cancer
    Bremer, K
    Micus, S
    Bremer, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1255 - 1255
  • [24] Clinical significance of CA 15-3 and CEA in detection of breast cancer recurrence
    Mok, C. W.
    Lim, S. K.
    Seah, J.
    Kam, J. W.
    Tan, S. M.
    BREAST, 2015, 24 : S107 - S108
  • [25] Comparison of the clinical relevance of CEA, CA 15-3 and MCA in breast cancer
    Bremer, K
    Micus, S
    Bremer, G
    Eberhard, A
    ONKOLOGIE, 1996, 19 (02): : 170 - 174
  • [26] Association of CA 15-3 and CEA with Liver Metastases in Patients with Breast Cancer
    Yazdani, Akram
    Akbari, Hossein
    CURRENT CANCER THERAPY REVIEWS, 2020, 16 (04) : 332 - 336
  • [27] Are CA 15-3, CEA and CA 125 Predictors for Lymphatic and Vascular Spread In Breast Cancer?
    Atalay, Can
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 218 - 224
  • [28] Elevated preoperative serum level of tumor markers CEA and CA 15-3 in breast cancer patients.
    Park, B.
    Kim, H.
    Oh, J.
    Kim, S.
    Kim, K.
    Sohn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 33S - 33S
  • [29] Low value of serum Ca 15-3 and CEA in monitoring trastuzumab based therapy of advanced breast cancer
    Duchnowska, R.
    Miedzinska-Maciejewska, M.
    Szczylik, C.
    Konieczna, M.
    Pietrzak, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 128 - 128
  • [30] Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
    Pedersen, Ann Christina
    Sorensen, Patricia Diana
    Jacobsen, Erik Hugger
    Madsen, Jonna Skov
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (07) : 1511 - 1519
12345